01-676-482
SARS Coronavirus Spike Protein Recombinant Mouse Monoclonal Antibody (17F706R), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 01-676-482-Each-of-1 | In Stock | ₹ 44,455.50 |
01-676-482 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,455.50
GST (18%): ₹ 8,001.99
Total Price: ₹ 52,457.49
Antigen
SARS Coronavirus Spike Protein
Classification
Monoclonal
Concentration
1.0 mg/mL
Formulation
PBS with 0.02% sodium azide
Host Species
Mouse
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG1
Applications
Western Blot
Clone
17F706R
Conjugate
Unconjugated
Gene Alias
Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2
Immunogen
Synthetic peptide corresponding to residues 1124-1140 of human SARS-Spike protein.
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- The immunogen is 100% (16/16) homologous to SARS-COV-2 (COVID-19) Spike protein
- The cross reactivity is not empirically tested
- This is the mouse recombinant monoclonal version of the clone 17F706 produced from mouse ascites
- It has recently been shown that SARS (severe acute respiratory syndrome) is caused by a human coronavirus
- Human coronaviruses are the major cause of upper respiratory tract illness, such as the common cold, in humans
- Coronaviruses are positive-stranded RNA viruses, featuring the largest viral RNA genomes known to date (27-31 kb)
- The first step in coronavirus infection is binding of the viral spike protein, a 139-kDa protein, to certain receptors on host cells
- The spike protein is the main surface antigen of the coronavirus
- The glycosylated spike protein (as well as the nucleocapsid protein) can be detected in infected cell culture supernatants with antisera from SARS patients.